177Lu-EDTMP for bone pain palliation in patients with bone metastases: Pharmacokinetics and toxicity evaluation using dose escalation schedule

被引：0
作者：
Saeed, Shabana [1 ]
Zaknun, John [3 ]
Jameel, Ghazal [2 ]
Ahmed, Naseer [2 ]
Irfan, Javaid [2 ]
Fatima, Shazia [2 ]
Qureshy, Ahmad [4 ]
Afzal, Muhammad Shahzad [5 ]
Mariani, Giuliano [6 ]
机构：
[1] Pakistan Inst Engn & Appl Sci, Islamabad, Pakistan
[2] Nucl Med Oncol & Radiotherapy Inst, Islamabad, Pakistan
[3] IAEA, Vienna, Austria
[4] Inst Nucl Med & Oncol, Lahore, Pakistan
[5] Punjab Inst Nucl Med, Faisalabad, Pakistan
[6] Univ Pisa, Pisa, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1211
引用
收藏
页数：2
相关论文
共 50 条
[41]   Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases [J].
Thapa, Pradeep ;
Nikam, Dilip ;
Das, Tapas ;
Sonawane, Geeta ;
Agarwal, Jai Prakash ;
Basu, Sandip .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (10) :1513-1519
[42]   Evaluation of Lu-177-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy [J].
Chakraborty, Sudipta ;
Balogh, Lajos ;
Das, Tapas ;
Polyak, Andras ;
Andocs, Gabor ;
Mathe, Domokos ;
Kiraly, Reka ;
Thuroczy, Julianna ;
Chaudhari, Pradip R. ;
Janoki, Gyoza. ;
Janoki, Gergely ;
Banerjee, Sharmila ;
Pillai, M. R. A. .
CURRENT RADIOPHARMACEUTICALS, 2016, 9 (01) :64-70
[43]   177Lu labelled polyaminophosphonates as potential agents for bone pain palliation [J].
Chakraborty, S ;
Das, T ;
Unni, PR ;
Sarma, HD ;
Samuel, G ;
Banerjee, S ;
Venkatesh, M ;
Ramamoorthy, N ;
Pillai, MRA .
NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (01) :67-74
[44]   [177Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results [J].
Madhav Prasad Yadav ;
Sanjana Ballal ;
Marian Meckel ;
Frank Roesch ;
Chandrasekhar Bal .
EJNMMI Research, 10
[45]   [177Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results [J].
Yadav, Madhav Prasad ;
Ballal, Sanjana ;
Meckel, Marian ;
Roesch, Frank ;
Bal, Chandrasekhar .
EJNMMI RESEARCH, 2020, 10 (01)
[46]   PHARMACOKINETICS AND TOXICITY OF SAMARIUM-153-EDTMP ADMINISTERED FOR BONE PAIN [J].
BAYOUTH, JE ;
MACEY, DJ ;
KASI, LP ;
FOSSELLA, FV .
JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) :P134-P134
[47]   SAMARIUM-153-EDTMP - PHARMACOKINETIC, TOXICITY AND PAIN RESPONSE USING AN ESCALATING DOSE SCHEDULE IN TREATMENT OF METASTATIC BONE CANCER [J].
FARHANGHI, M ;
HOLMES, RA ;
VOLKERT, WA ;
LOGAN, KW ;
SINGH, A .
JOURNAL OF NUCLEAR MEDICINE, 1992, 33 (08) :1451-1458
[48]   177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation [J].
Das, T ;
Chakraborty, S ;
Unni, PR ;
Banerjee, S ;
Samuel, G ;
Sarma, HD ;
Venkatesh, M ;
Pillai, MRA .
APPLIED RADIATION AND ISOTOPES, 2002, 57 (02) :177-184
[49]   Preliminary studies on 177Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation [J].
Abbasi, Imtiaz Ahmed .
NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (06) :763-769
[50]   Bone pain palliation with Strontium-89 in cancer patients with bone metastases [J].
Giammarile, F ;
Mognetti, T ;
Resche, I .
QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 2001, 45 (01) :78-83
12345